Evidence map›Paper›PMID 26424572›Full record

ReviewScience translational medicine2015

Lessons from Ebola: Improving infectious disease surveillance to inform outbreak management.

Mark E J Woolhouse, Andrew Rambaut, Paul Kellam

Abstract readReview
In one paragraph

Review in Science translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Global Health Perspectives on Race in Research: Neocolonial Extraction and Local Marginalization.International journal of environmental research and public health · 2023
    Review
  10. Article
  11. Diagnostics of Ebola virus.Frontiers in public health · 2023
    Review
  12. Article
  13. A framework for measuring timeliness in the outbreak response path: lessons learned from the Middle East respiratory syndrome (MERS) epidemic, September 2012 to January 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.International journal of environmental research and public health · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mark E J WoolhouseCentre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, UK. mark.woolhouse@ed.ac.uk.
Andrew RambautCentre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, UK. Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.
Paul KellamWellcome Trust Sanger Institute, Cambridge CB10 1RQ, UK. Division of Infection & Immunity, University College London, London WC1E 6BT, UK.

Funding

Wellcome Trust 093724Wellcome Trust 095831
6 · The paper itself

Abstract

The current Ebola virus disease outbreak in West Africa has revealed serious shortcomings in national and international capacity to detect, monitor, and respond to infectious disease outbreaks as they occur. Recent advances in diagnostics, risk mapping, mathematical modeling, pathogen genome sequencing, phylogenetics, and phylogeography have the potential to improve substantially the quantity and quality of information available to guide the public health response to outbreaks of all kinds.

Indexed as

Population SurveillanceCommunicable DiseasesDisease OutbreaksEbolavirusHumansModels, BiologicalSequence Analysis, DNA

Identifiers

PMID26424572
PMCPMC5819730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.